Specific interactions of HeLa cell proteins with Coxsackievirus B3 RNA: La autoantigen binds differentially to multiple sites within the 5′ untranslated region

Virus Research

Volumn 90, Issue 1-2, 2002, Pages 23-36

  Cheung, Paul ^a,b   Zhang, Mary ^a,b   Yuan, Ji ^a,b   Chau, David ^a,b   Yanagawa, Bobby ^a,b   McManus, Bruce ^a,b   Yang, Decheng ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

Coxsackievirus B3; Internal ribosomal entry site; La autoantigen; Protein RNA interaction; Translation initiation; Untranslated sequence

Indexed keywords

AUTOANTIGEN; CELL PROTEIN; GLUTATHIONE TRANSFERASE; RNA;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; COXSACKIE VIRUS B3; CROSS LINKING; EUKARYOTE; FEMALE; HELA CELL; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; RNA TRANSLATION; TRANSLATION INITIATION; ULTRAVIOLET RADIATION; UNTRANSLATED REGION;

5' UNTRANSLATED REGIONS; AUTOANTIGENS; BINDING SITES; BINDING, COMPETITIVE; CROSS-LINKING REAGENTS; ENTEROVIRUS B, HUMAN; HELA CELLS; HUMANS; PROTEIN BIOSYNTHESIS; RIBONUCLEOPROTEINS; RIBOSOMES; RNA, VIRAL; VIRAL PROTEINS;

COXSACKIEVIRUS; EUKARYOTA; VIBRIO PHAGE NT-1;

EID: 0036891234     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(02)00138-7     Document Type: Article

References (58)

1. Ali N., Siddiqui A. Interaction of polypyrimidine tract-binding protein with the 5' noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation. J. Virol. 69:1995;6367-6375.
2. Ali N., Siddiqui A. The La antigen binds 5' noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proc. Natl. Acad. Sci. USA. 94:1997;2249-2254.
3. Alspaugh M.A., Tan E.M. Antibodies to cellular antigens in Sjogren's syndrome. J. Clin. Invest. 55:1975;1067-1073.
4. Andino R., Rieckhof G.E., Achacoso P.L., Baltimore D. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA. EMBO J. 12:1993;3587-3598.
5. Blyn L.B., Towner J.S., Semler B.L., Ehrenfeld E. Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J. Virol. 71:1997;6243-6246.
6. Carter M.S., Sarnow P. Distinct mRNAs that encode La autoantigen are differentially expressed and contain internal ribosome entry sites. J. Biol. Chem. 275:2000;28301-28307.
7. Carthy C.M., Yang D., Anderson D.R., Wilson J.E., McManus B.M. Myocarditis as systemic disease: new perspectives on pathogenesis. Clin. Exp. Pharmacol. Physiol. 24:1997;997-1003.
8. Chapman N.M., Tu Z., Tracy S., Gauntt C.J. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch. Virol. 135:1994;115-130.
9. Cherry, J.D., 1995. Enteroviruses. Remington, J.S., Klein, K.O., (Eds.), Infectious Diseases of the Fetus and Newborn Infant, 4th Ed. Saunders, W.H., Philadelphia, pp. 404-446.
10. Crosio C., Boyl P.P., Loreni F., Pierandrei-Amaldi P., Amaldi F. La protein has a positive effect on the translation of top mRNAs in vivo. Nucleic Acids Res. 28:2000;2927-2934.
11. De B.P., Gupta S., Zhao H., Drazba J.A., Banerjee A.K. Specific interaction in vitro and in vivo of glyceraldehyde-3-phosphate dehydrogenase and LA protein with cis-acting RNAs of human parainfluenza virus type 3. J. Biol. Chem. 271:1996;24728-24735.
12. Dildine S.L., Semler B.L. Conservation of RNA-protein interactions among picornaviruses. J.Virol. 66:1992;4364-4376.
13. Drew J., Belsham G.J. Trans complementation by RNA of defective foot-and-mouth disease virus internal ribosome entry site elements. J. Virol. 68:1994;697-703.
14. Dunn J.J., Chapman N.M., Tracy S., Romero J.R. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region. J. Virol. 74:2000;4787-4794.
15. Etchison D., Milburn S.C., Edery I., Sonenberg N., Hershey J.W. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J. Biol. Chem. 257:1982;14806-14810.
16. Gamarnik A.V., Andino R. Switch from translation to RNA replication in a positive-stranded RNA virus. Genes Dev. 12:1998;2293-2304.
17. Gauntt C., Godney E., Lutton C., Arizipe H., Chapman N., Tracy S., Revtyak G., Valente A., Rozek M. Mechanisms of coxsackievirus induced acute myocarditis in the mouse. De la Maza L., Peterson E. Medical Virology (8th). 1989;161-182 Lawrence Erlbaum Associates, Hellsdale, N.J.
18. Gingras A.C., Raught B., Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68:1999;913-963.
19. Gottlieb E., Steitz J.A. Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III. EMBO J. 8:1989a;851-861.
20. Gottlieb E., Steitz J.A. The RNA binding protein La influences both the accuracy and the efficiency of RNA polymerase III transcription in vitro. EMBO J. 8:1989b;841-850.
21. Gutierrez-Escolano A.L., Brito Z.U., del Angel R.M., Jiang X. Interaction of cellular proteins with the 5' end of Norwalk virus genomic RNA. J. Virol. 74:2000;8558-8562.
22. Haller A.A., Semler B.L. Stem-loop structure synergy in binding cellular proteins to the 5' non-coding region of poliovirus RNA. Virology. 206:1995;923-934.
23. Hellen C.U., Witherell G.W., Schmid M., Shin S.H., Pestova T.V., Gil A., Wimmer E. A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. Proc. Natl. Acad. Sci. USA. 90:1993;7642-7646.
24. Isoyama T., Kamoshita N., Yasui K., Iwai A., Shiroki K., Toyoda H., Yamada A., Takasaki Y., Nomoto A. Lower concentration of La protein required for internal ribosome entry on hepatitis C virus RNA than on poliovirus RNA. J. Gen. Virol. 80:((Pt 9)):1999;2319-2327.
25. Jackson R.J., Kaminski A. Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond. RNA. 1:1995;985-1000.
26. Johnson R.A., Palacios I. Dilated cardiomyopathies of the adult (first of two parts). N. Engl. J. Med. 307:1982;1051-1058.
27. Kandolf R., Ameis D., Kirschner P., Canu A., Hofschneider P.H. In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc. Natl. Acad. Sci. USA. 84:1987;6272-6276.
28. Keeling P.J., Lukaszyk A., Poloniecki J., Caforio A.L., Davies M.J., Booth J.C., McKenna W.J. A prospective case-control study of antibodies to coxsackie B virus in idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 23:1994;593-598.
29. Kim Y.K., Jang S.K. La protein is required for efficient translation driven by encephalomyocarditis virus internal ribosomal entry site. J. Gen. Virol. 80:((Pt 12)):1999;3159-3166.
30. Klingel K., Stephan S., Sauter M., Zell R., McManus B.M., Bultmann B., Kandolf R. Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J. Virol. 70:1996;8888-8895.
31. Kolupaeva V.G., Hellen C.U., Shatsky I.N. Structural analysis of the interaction of the pyrimidine tract-binding protein with the internal ribosomal entry site of encephalomyocarditis virus and foot-and-mouth disease virus RNAs. RNA. 2:1996;1199-1212.
32. Kolupaeva V.G., Pestova T.V., Hellen C.U., Shatsky I.N. Translation eukaryotic initiation factor 4G recognizes a specific structural element within the internal ribosome entry site of encephalomyocarditis virus RNA. J. Biol. Chem. 273:1998;18599-18604.
33. La Monica N., Racaniello V.R. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J. Virol. 63:1989;2357-2360.
34. Lamphear B.J., Kirchweger R., Skern T., Rhoads R.E. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation. J. Biol. Chem. 270:1995;21975-21983.
35. Liu Z., Carthy C.M., Cheung P., Bohunek L., Wilson J.E., McManus B.M., Yang D. Structural and functional analysis of the 5' untranslated region of coxsackievirus B3 RNA: In vivo translational and infectivity studies of full-length mutants. Virology. 265:1999;206-217.
36. Lopez D.Q., Martinez-Salas E. Conserved structural motifs located in distal loops of aphthovirus internal ribosome entry site domain 3 are required for internal initiation of translation. J. Virol. 71:1997;4171-4175.
37. Macadam A.J., Ferguson G., Burlison J., Stone D., Skuce R., Almond J.W., Minor P.D. Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture. Virology. 189:1992;415-422.
38. Martinez-Salas E., Ramos R., Lafuente E., Lopez D.Q. Functional interactions in internal translation initiation directed by viral and cellular IRES elements. J. Gen. Virol. 82:2001;973-984.
39. Martino T.A., Liu P., Sole M.J. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ. Res. 74:1994;182-188.
40. Mattioli M., Reichlin M. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen. Arthritis Rheum. 17:1974;421-429.
41. McManus B.M., Chow L.H., Wilson J.E., Anderson D.R., Gulizia J.M., Gauntt C.J., Klingel K.E., Beisel K.W., Kandolf R. Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin. Immunol. Immunopathol. 68:1993;159-169.
42. Meerovitch K., Svitkin Y.V., Lee H.S., Lejbkowicz F., Kenan D.J., Chan E.K., Agol V.I., Keene J.D., Sonenberg N. La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J. Virol. 67:1993;3798-3807.
43. Merrick W.C. Mechanism and regulation of eukaryotic protein synthesis. Microbiol. Rev. 56:1992;291-315.
44. Peek R., Pruijn G.J., Van Venrooij W.J. Interaction of the La (SS-B) autoantigen with small ribosomal subunits. Eur. J. Biochem. 236:1996;649-655.
45. Pellizzoni L., Cardinali B., Lin-Marq N., Mercanti D., Pierandrei-Amaldi P. A Xenopus laevis homologue of the La autoantigen binds the pyrimidine tract of the 5' UTR of ribosomal protein mRNAs in vitro: implication of a protein factor in complex formation. J. Mol. Biol. 259:1996;904-915.
46. Pestova T.V., Hellen C.U., Wimmer E. Translation of poliovirus RNA: role of an essential cis-acting oligopyrimidine element within the 5' nontranslated region and involvement of a cellular 57-kilodalton protein. J. Virol. 65:1991;6194-6204.
47. Robertson M.E., Seamons R.A., Belsham G.J. A selection system for functional internal ribosome entry site (IRES) elements: analysis of the requirement for a conserved GNRA tetraloop in the encephalomyocarditis virus IRES. RNA. 5:1999;1167-1179.
48. Rohll J.B., Percy N., Ley R., Evans D.J., Almond J.W., Barclay W.S. The 5'-untranslated regions of picornavirus RNAs contain independent functional domains essential for RNA replication and translation. J. Virol. 68:1994;4384-4391.
49. Schultz D.E., Hardin C.C., Lemon S.M. Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5'-nontranslated RNA of hepatitis A virus. J. Biol. Chem. 271:1996;14134-14142.
50. Sizova D.V., Kolupaeva V.G., Pestova T.V., Shatsky I.N., Hellen C.U. Specific interaction of eukaryotic translation initiation factor 3 with the 5' nontranslated regions of hepatitis C virus and classical swine fever virus RNAs. J. Virol. 72:1998;4775-4782.
51. Sole M.J., Liu P. Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J. Am. Coll. Cardiol. A22:1993;99A-105A.
52. Svitkin Y.V., Meerovitch K., Lee H.S., Dholakia J.N., Kenan D.J., Agol V.I., Sonenberg N. Internal translation initiation on poliovirus RNA: further characterization of La function in poliovirus translation in vitro. J. Virol. 68:1994;1544-1550.
53. Thomas A.A., Scheper G.C., Kleijn M., De Boer M., Voorma H.O. Dependence of the adenovirus tripartite leader on the p220 subunit of eukaryotic initiation factor 4F during in vitro translation. Effect of p220 cleavage by foot-and-mouth-disease-virus L-protease on in vitro translation. Eur. J. Biochem. 207:1992;471-477.
54. Tu Z., Chapman N.M., Hufnagel G., Tracy S., Romero J.R., Barry W.H., Zhao L., Currey K., Shapiro B. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region. J. Virol. 69:1995;4607-4618.
55. Villa-Komaroff L., Guttman N., Baltimore D., Lodishi H.F. Complete translation of poliovirus RNA in a eukaryotic cell-free system. Proc. Natl. Acad. Sci. USA. 72:1975;4157-4161.
56. Yang D., Wilson J.E., Anderson D.R., Bohunek L., Cordeiro C., Kandolf R., McManus B.M. In vitro mutational and inhibitory analysis of the cis-acting translational elements within the 5' untranslated region of coxsackievirus B3: potential targets for antiviral action of antisense oligomers. Virology. 228:1997;63-73.
57. Yi M.K., Shultz D.E., Lemon S.M. Functional significance of the interaction of hepatitis A virus RNA with glyercaldehyde 3-phosphate dehydrogenase (GAPDH): opposing effects of GAPDH and polypyrimidine tract binding protein on internal ribosomal entry site function. J. Virol. 74:2000;6459-6468.
58. Zuker M. On finding all suboptimal foldings of an RNA molecule. Science. 244:1989;48-52.